The chemical class known as ARL5C Activators encompasses a broad spectrum of compounds that can indirectly modulate the activity of the ARL5C protein, a member of the ARF-like protein family involved in various cellular processes. These activators are not direct ligands of ARL5C but exert their influence through the modulation of signaling pathways and cellular mechanisms that can lead to the activation of ARL5C. The diversity within this class is significant, ranging from small molecule agonists to larger biomolecules, each with unique biochemical properties and modes of action. For instance, some members of this class, like Forskolin and Dibutyryl-cAMP, function by elevating intracellular cyclic AMP (cAMP) levels, thereby activating cAMP-dependent protein kinase A (PKA) and other cAMP-responsive pathways. This cascade can indirectly influence the activity of ARL5C by altering the cellular environment and the phosphorylation status of various proteins that interact with or regulate ARL5C.
Other examples in this class include compounds like PMA, which activates protein kinase C (PKC), and Ionomycin, a calcium ionophore that increases intracellular calcium levels, both of which impact signaling pathways that can indirectly modulate ARL5C activity. Additionally, growth factors such as EGF and VEGF, by activating their respective receptors, initiate a series of downstream signaling events that can intersect with pathways involving ARL5C. The role of these activators is often to initiate or amplify signaling cascades that ultimately lead to changes in the activity or function of ARL5C, albeit indirectly. The mechanistic link between these activators and ARL5C activation is complex and involves multiple layers of regulation, including post-translational modifications, interactions with other cellular proteins, and changes in gene expression patterns. While the direct effects of these compounds on ARL5C are not explicitly defined, their ability to modulate cellular pathways that intersect with ARL5C's function highlights the intricate network of cellular signaling and the potential for cross-talk between different pathways in regulating protein activities.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can influence various signaling pathways, potentially activating ARL5C. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which is involved in various signaling cascades and could indirectly activate ARL5C. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, raising intracellular calcium levels, affecting calcium-dependent signaling pathways that might activate ARL5C. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAP kinases, potentially influencing signaling pathways that could activate ARL5C. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can activate PKA and other cAMP-dependent pathways, potentially influencing ARL5C activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates insulin receptor signaling, potentially impacting pathways that could activate ARL5C. | ||||||